[HTML][HTML] European Association of Urology guidelines on renal cell carcinoma: the 2022 update
B Ljungberg, L Albiges, Y Abu-Ghanem, J Bedke… - European urology, 2022 - Elsevier
Abstract Context The European Association of Urology (EAU) Renal Cell Carcinoma (RCC)
Guideline Panel has prepared evidence-based guidelines and recommendations for the …
Guideline Panel has prepared evidence-based guidelines and recommendations for the …
Role of imaging in renal cell carcinoma: A multidisciplinary perspective
AM Abou Elkassem, SS Lo, AJ Gunn, BM Shuch… - Radiographics, 2021 - pubs.rsna.org
With the expansion in cross-sectional imaging over the past few decades, there has been an
increase in the number of incidentally detected renal masses and an increase in the …
increase in the number of incidentally detected renal masses and an increase in the …
European association of urology guidelines on renal cell carcinoma: the 2019 update
B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah… - European urology, 2019 - Elsevier
Abstract Context The European Association of Urology Renal Cell Carcinoma (RCC)
Guideline Panel has prepared evidence-based guidelines and recommendations for the …
Guideline Panel has prepared evidence-based guidelines and recommendations for the …
Radiomics in renal cell carcinoma—a systematic review and meta-analysis
J Mühlbauer, L Egen, KF Kowalewski, M Grilli… - Cancers, 2021 - mdpi.com
Simple Summary Radiomics may answer questions where the conventional interpretation of
medical imaging has limitations. The aim of our systematic review and meta-analysis was to …
medical imaging has limitations. The aim of our systematic review and meta-analysis was to …
The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma
S Raveenthiran, R Esler, J Yaxley, S Kyle - European Journal of Nuclear …, 2019 - Springer
Abstract Purpose The role of 68 Ga-PSMA PET/CT in the staging of prostate cancer is well
known. PSMA is also overexpressed in the neovasculature of other tumours including renal …
known. PSMA is also overexpressed in the neovasculature of other tumours including renal …
Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma
R Kubiliūtė, K Žukauskaitė, A Žalimas, A Ulys… - Journal of Cancer …, 2022 - Springer
Objective Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney tumor
characterized by the highest mortality rate of the genitourinary cancers, and, therefore, new …
characterized by the highest mortality rate of the genitourinary cancers, and, therefore, new …
An automated surgical decision-making framework for partial or radical nephrectomy based on 3D-CT multi-level anatomical features in renal cell carcinoma
H Yang, K Wu, H Liu, P Wu, Y Yuan, L Wang, Y Liu… - European …, 2023 - Springer
Objectives To determine whether 3D-CT multi-level anatomical features can provide a more
accurate prediction of surgical decision-making for partial or radical nephrectomy in renal …
accurate prediction of surgical decision-making for partial or radical nephrectomy in renal …
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual …
Purpose The objective of this study was to perform an intra-individual dual tracer
comparison of Fluorodeoxyglucose (FDG) and Prostate Specific Membrane Antigen (PSMA) …
comparison of Fluorodeoxyglucose (FDG) and Prostate Specific Membrane Antigen (PSMA) …
Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies
V Schiavoni, R Campagna, V Pozzi, M Cecati… - Cancers, 2023 - mdpi.com
Simple Summary The aim of the present review is to discuss novel prognostic and
therapeutic markers for clear cell renal cell carcinoma, a subtype of renal cell carcinoma …
therapeutic markers for clear cell renal cell carcinoma, a subtype of renal cell carcinoma …
Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries
WW Sung, PY Ko, WJ Chen, SC Wang, SL Chen - Scientific Reports, 2021 - nature.com
The incidence and mortality rates in kidney cancer (KC) are increasing. However, the trends
for mortality have varied among regions over the past decade, which may be due to the …
for mortality have varied among regions over the past decade, which may be due to the …